JP2022547080A - 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 - Google Patents

超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 Download PDF

Info

Publication number
JP2022547080A
JP2022547080A JP2022514679A JP2022514679A JP2022547080A JP 2022547080 A JP2022547080 A JP 2022547080A JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022547080 A JP2022547080 A JP 2022547080A
Authority
JP
Japan
Prior art keywords
elv
vlc
carbon
cells
erovanoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514679A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021046448A5 (https=
JP2022547080A5 (https=
Inventor
リカルド パラシオス ペレーズ
ニコラス ジー． バザン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2022547080A publication Critical patent/JP2022547080A/ja
Publication of JPWO2021046448A5 publication Critical patent/JPWO2021046448A5/ja
Publication of JP2022547080A5 publication Critical patent/JP2022547080A5/ja
Priority to JP2025111395A priority Critical patent/JP2025143368A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022514679A 2019-09-04 2020-09-04 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 Pending JP2022547080A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025111395A JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962895737P 2019-09-04 2019-09-04
US62/895,737 2019-09-04
US201962923770P 2019-10-21 2019-10-21
US62/923,770 2019-10-21
US201962924359P 2019-10-22 2019-10-22
US62/924,359 2019-10-22
US202062964995P 2020-01-23 2020-01-23
US62/964,995 2020-01-23
PCT/US2020/049541 WO2021046448A1 (en) 2019-09-04 2020-09-04 Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025111395A Division JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Publications (3)

Publication Number Publication Date
JP2022547080A true JP2022547080A (ja) 2022-11-10
JPWO2021046448A5 JPWO2021046448A5 (https=) 2024-04-02
JP2022547080A5 JP2022547080A5 (https=) 2024-04-02

Family

ID=74853054

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022514679A Pending JP2022547080A (ja) 2019-09-04 2020-09-04 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法
JP2025111395A Pending JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025111395A Pending JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Country Status (9)

Country Link
US (1) US20220339134A1 (https=)
EP (1) EP4025201A4 (https=)
JP (2) JP2022547080A (https=)
CN (1) CN114650814A (https=)
AU (1) AU2020343029A1 (https=)
BR (1) BR112022003985A2 (https=)
CA (1) CA3153088A1 (https=)
MX (1) MX2022002687A (https=)
WO (1) WO2021046448A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4210689A4 (en) * 2020-09-10 2024-11-13 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS, HYDROXYLATED ELOVANOID DERIVATIVES AND METHODS OF USE THEREOF
CN118524834A (zh) * 2021-12-03 2024-08-20 株式会社日水 氧化应激缓和方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018175288A1 (en) * 2017-03-20 2018-09-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102256990B (zh) * 2008-10-03 2014-09-24 聚糖生物科学有限责任公司 阴离子寡糖轭合物
US20130190399A1 (en) * 2009-10-31 2013-07-25 Martek Biosciences Corporation Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA)
JP7025212B2 (ja) * 2015-02-09 2022-02-24 ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ 炎症性、変性及び神経変性疾患の治療のための化合物、組成物及び方法
US20170014365A1 (en) * 2015-07-14 2017-01-19 The Board Of Regents Of The University Of Oklahoma Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use
WO2017077528A2 (en) * 2015-11-02 2017-05-11 Salzman Lovelace Investments, Ltd. Methods and pharmaceutical compositions for treatment of lung inflammation
US20220226270A1 (en) * 2019-04-04 2022-07-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018175288A1 (en) * 2017-03-20 2018-09-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
黒田悦史他: "「微細粒子による免疫系の活性化とアレルギー性炎症」", 日衛誌(JPN. J. HYG.), vol. 72, JPN6024030038, 2017, pages 27 - 31, ISSN: 0005539558 *

Also Published As

Publication number Publication date
BR112022003985A2 (pt) 2022-05-24
MX2022002687A (es) 2022-06-16
CA3153088A1 (en) 2021-03-11
EP4025201A1 (en) 2022-07-13
CN114650814A (zh) 2022-06-21
WO2021046448A1 (en) 2021-03-11
AU2020343029A1 (en) 2022-03-31
JP2025143368A (ja) 2025-10-01
US20220339134A1 (en) 2022-10-27
EP4025201A4 (en) 2023-08-30

Similar Documents

Publication Publication Date Title
JP2025143368A (ja) 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法
US20200338097A1 (en) Use of a heterocyclic bcl-2 inhibitor for removing senescent cells and treating senescence-associated conditions
CA3000985C (en) Method for treating neurodegenerative diseases
JP2019511495A (ja) ＧＳＫ３β阻害薬チデグルシブによるＣＤＫＬ５障害の治療
WO2013070879A1 (en) Methods for treating spinal cord injury with lpa receptor antagonists
US9956202B2 (en) Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits
Park et al. Suppressive effects of britanin, a sesquiterpene compound isolated from Inulae flos, on mast cell-mediated inflammatory responses
WO2017135753A1 (ko) 혈관내피성장인자를 과발현한 줄기세포를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물
JP2017128578A (ja) 腎疾患の治療におけるモノおよびジカルボン酸のアミドの使用
US20240075004A1 (en) Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
AU2025220850A1 (en) Compositions for regulating homeostasis of cortisol and improving sleep quality and methods of use and production thereof
US9950036B2 (en) Treatment of mood and stress related disorders
JP6928450B2 (ja) エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物及び方法
WO2021247594A1 (en) Dihomo-gamma linolenic acid (dgla) is a novel senolytic
JP2022541720A (ja) 細胞外小胞に含まれるｅｎａｍｐｔの産生および使用
JP5788907B2 (ja) 疾患の治療に使用される化合物
JP2019530741A (ja) 神経保護及び神経疾患におけるｃｇｒｐ受容体アンタゴニストの使用
US11925642B2 (en) Regulation of eIF4E activity for migraine therapy
US20240390377A1 (en) Composition for the prevention or treatment of neurodegenerative or motor neuron diseases comprising halofuginone as an active ingredient
EP4210689A1 (en) Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
CN118593706A (zh) 通过调节Endoglin治疗痴呆的方法
Yanamoto et al. Repeated application of an electric field increases BDNF in the brain, enhances spatial learning, and induces infarct tolerance
WO2022217035A1 (en) Activators of integrated stress response pathway for protection against ferroptosis
KR20220024145A (ko) 뇌전증 발생의 예방 및/또는 치료를 위한 마리마스타트의 용도
CA3101041A1 (en) Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220907

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230901

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240801

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241030

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250303